Medindia LOGIN REGISTER
Medindia
Advertisement

Celator(R) Pharmaceuticals to Present at 2008 BIO International Convention

Tuesday, June 17, 2008 General News
Advertisement
PRINCETON, N.J., June 16 Celator Pharmaceuticals todayannounced that John Bennett, head of business development, is scheduled topresent at the BIO Business Forum during the Biotechnology IndustryOrganization (BIO) International Convention in San Diego. Mr. Bennett willprovide a corporate overview and an update on Celator's clinical developmentprograms. The presentation will be held on Wednesday, June 18, 2008 at 3:30PDT in Room 3 of the San Diego Convention Center.
Advertisement

About Celator

Celator Pharmaceuticals, Inc., is a privately held pharmaceutical companyworking to develop new and more effective therapies to treat cancer.CombiPlex(TM), the company's drug ratio technology platform, represents arevolutionary new approach to the development of combination therapies basedon identifying a fixed, synergistic ratio of the drugs pre-clinically,incorporating that ratio in a drug delivery vehicle and maintaining the ratioin patients. The company pipeline includes: CPX-1 (a liposomal formulation ofirinotecan:floxuridine), currently in a Phase 2 trial in patients withcolorectal cancer; CPX-351 (a liposomal formulation ofcytarabine:daunorubicin), currently in a Phase 1 trial in patients withleukemia; CPX 571 (a liposomal formulation of irinotecan:cisplatin), apreclinical stage compound; and multiple research programs. Based on theapplications of CombiPlex, Celator is positioned to advance a broad pipelineof combination therapies involving both previously approved and novel drugagents. For more information, please visit the company's website atwww.celatorpharma.com.

SOURCE Celator Pharmaceuticals
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close